The Questions Cognitive Decline Practitioners Are Asking Right Now
Highlights from a recent “Ask Me Anything” with Kristine Burke, MD
One of the most valuable aspects of the TruNeura community is the opportunity for practitioners to bring real-world challenges directly to experts who are doing this work every day.
In a recent AMA session, TruNeura Co-Founder Kristine Burke, MD fielded a wide range of practitioner questions spanning mold exposure, patient engagement, clinical complexity, care planning, and the realities of implementing precision medicine approaches for cognitive decline.
While the discussion covered many different scenarios, a common theme emerged: successful cognitive decline care requires far more than following a protocol. It requires clinical judgment, pattern recognition, and the ability to navigate the unique circumstances of each patient.
When Mold Becomes Part of the Cognitive Decline Story
One of the most active areas of discussion centered around mold and mycotoxin exposure.
Practitioners brought forward questions involving patients with persistent symptoms despite treatment, uncertainty around interpreting test results, concerns about ongoing environmental exposures, and the challenge of helping patients make difficult decisions when mold may still be contributing to cognitive decline.
Dr. Burke emphasized that environmental contributors are rarely simple. The conversation explored how practitioners can think through these situations systematically while balancing clinical findings, patient circumstances, and evolving evidence.
The discussion reflected an important reality of precision medicine: environmental factors such as mold are often a significant piece of the puzzle and require both clinical expertise and patient-specific decision-making.
The Challenge of Patient Motivation and Follow-Through
Another recurring topic involved patient engagement.
Many practitioners encounter situations where patients understand the recommendations but struggle to implement them consistently. Whether related to lifestyle changes, treatment adherence, caregiver dynamics, or competing priorities, these barriers can significantly impact outcomes.
Rather than focusing solely on what interventions to recommend, the conversation explored how practitioners can better support patients through the behavior change process itself.
For many attendees, this highlighted an important truth: sometimes the biggest obstacle is not knowing what to do. It’s helping patients successfully do it.
Why Community-Based Learning Matters
Perhaps the biggest takeaway from the session wasn’t any single clinical topic.
It was the power of collaborative learning.
The questions raised during the AMA reflected the realities practitioners encounter every day. Complex patients. Incomplete information. Competing priorities. Unclear next steps.
By bringing these challenges into a community of clinicians focused on cognitive decline, practitioners gain access to the collective experience, perspective, and problem-solving that simply isn’t available through static courses or textbooks alone.
These conversations are a reminder that advancing cognitive decline care is not just about acquiring knowledge. It’s about learning how to apply that knowledge in the context of real patients and real clinical decisions.
For practitioners looking to build confidence in this rapidly evolving field, that kind of support can make all the difference.
